The SLC22 family with transporters of organic cations, anions and zwitterions

Molecular Aspects of Medicine

Volumn 34, Issue 2-3, 2013, Pages 413-435

  Koepsell, Hermann ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anion transporter; Cation transporter; Drug excretion; Drug transporter; SLC22; Urate transporter

Indexed keywords

AMPHOLYTE; ANTIPORTER; CISPLATIN; DOXORUBICIN; METFORMIN; MITOXANTRONE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 10; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; ORGANIC ANION TRANSPORTER 5; ORGANIC ANION TRANSPORTER 6; ORGANIC ANION TRANSPORTER 7; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; ORGANIC CATION TRANSPORTER 6; PROTEIN BOIT; PROTEIN FLIPT1; PROTEIN OCTL2; PROTEIN OCTN1; PROTEIN OCTN2; PROTEIN TYROSINE KINASE INHIBITOR; PROTON PUMP INHIBITOR; ROSIGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT;

ALPHA HELIX; BRAIN; BREAST CANCER; CARNITINE DEFICIENCY; CELL MEMBRANE; CROHN DISEASE; DRUG EXCRETION; DRUG MECHANISM; DRUG TARGETING; DRUG UPTAKE; GENE; GENE FUNCTION; GENE MUTATION; GOUT; HEART; HEART DISEASE; HOMEOSTASIS; HUMAN; HYPOURICEMIA; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; SLC22 GENE; SLC22A1 GENE; SLC22A10 GENE; SLC22A11 GENE; SLC22A12 GENE; SLC22A13 GENE; SLC22A14 GENE; SLC22A15 GENE; SLC22A16 GENE; SLC22A17 GENE; SLC22A2 GENE; SLC22A20 GENE; SLC22A23 GENE; SLC22A24 GENE; SLC22A25 GENE; SLC22A3 GENE; SLC22A31 GENE; SLC22A4 GENE; SLC22A5 GENE; SLC22A6 GENE; SLC22A7 GENE; SLC22A8 GENE; SLC22A9 GENE; SMALL INTESTINE ABSORPTION; URIC ACID BLOOD LEVEL;

ABSORPTION; BRAIN; CARNITINE; HUMANS; INTESTINE, SMALL; ION PUMPS; KETOGLUTARIC ACIDS; KIDNEY; LIVER; MODELS, MOLECULAR; MULTIGENE FAMILY; NEUROTRANSMITTER AGENTS; NUCLEOTIDES, CYCLIC; ORGANIC CATION TRANSPORT PROTEINS; ORGANIC CATION TRANSPORTER 1; PROSTAGLANDINS; PROTEIN CONFORMATION; URIC ACID;

EID: 84875181483     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2012.10.010     Document Type: Review

References (202)

1. G. Ahlin, L. Chen, L. Lazorova, Y. Chen, A.G. Ianculescu, R.L. Davis, K.M. Giacomini, and P. Artursson Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions Pharmacogenomics 11 2010 400 411
2. S.-Y. Ahn, S.A. Eraly, I. Tsigelny, and S.K. Nigam Interaction of organic cations with organic anion transporters J. Biol. Chem. 284 2009 31422 31430
3. M. Alebouyeh, M. Takeda, M.L. Onozato, A. Tojo, R. Noshiro, H. Hasannejad, J. Inatomi, S. Narikawa, X.-L. Huang, S. Khamdang, N. Anzai, and H. Endou Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites J. Pharmacol. Sci. 93 2003 430 436
4. N. Anzai, K. Ichida, P. Jutabha, T. Kimura, E. Babu, C.J. Jin, S. Srivastava, K. Kitamura, I. Hisatome, H. Endou, and H. Sakurai Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans J. Biol. Chem. 283 2008 26834 26838
5. N. Anzai, Y. Kanai, and H. Endou Organic anion transporter family: current knowledge J. Pharmacol. Sci. 100 2006 411 426
6. M. Aoki, T. Terada, M. Kajiwara, K. Ogasawara, I. Ikai, O. Ogawa, T. Katsura, and K.-I. Inui Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation Am. J. Physiol. Renal Physiol. 295 2008 F165 F170
7. M. Aouida, R. Poulin, and D. Ramotar The human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5 J. Biol. Chem. 285 2010 6275 6284
8. A.C. Aperia Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism Annu. Rev. Physiol. 62 2000 621 647
9. A.R. Asif, J. Steffgen, M. Metten, R.W. Grunewald, G.A. Müller, A. Bahn, G. Burckhardt, and Y. Hagos Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells Pflugers Arch.-Eur. J. Physiol. 450 2005 88 95
10. A. Bacq, L. Balasse, G. Biala, B. Guiard, A.M. Gardier, A. Schinkel, F. Louis, V. Vialou, M.-P. Martres, C. Chevarin, M. Hamon, B. Giros, and S. Gautron Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response Mol. Psychiatry 17 2011 926 938
11. N.L. Baganz, R.E. Horton, A.S. Calderon, W.A. Owens, J.L. Munn, L.T. Watts, N. Koldzic-Zivanovic, N.A. Jeske, W. Koek, G.M. Toney, and L.C. Daws Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice Proc. Natl. Acad. Sci. U.S.A. 105 2008 18976 18981
12. A. Bahn, Y. Hagos, S. Reuter, D. Balen, H. Brzica, W. Krick, B.C. Burckhardt, I. Sabolic, and G. Burckhardt Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13) J. Biol. Chem. 283 2008 16332 16341
13. S.A. Barros, C. Srimaroeng, J.L. Perry, R. Walden, N. Dembla-Rajpal, D.H. Sweet, and J.B. Pritchard Activation of protein kinase Cξ increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transport J. Biol. Chem. 284 2009 2672 2679
14. K. Bleasby, J.C. Castle, C.J. Roberts, C. Cheng, W.J. Bailey, J.F. Sina, A.V. Kulkarni, M.J. Hafey, R. Evers, J.M. Johnson, R.G. Ulrich, and J.G. Slatter Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition Xenobiotica 36 2006 963 988
15. K.P. Brady, H. Dushkin, D. Förnzler, T. Koike, F. Magner, H. Her, S. Gullans, G.V. Segre, R.M. Green, and D.R. Beier A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse Genomics 56 1999 254 261
16. S. Brast, A. Grabner, S. Sucic, H.H. Sitte, E. Hermann, H. Pavenstädt, E. Schlatter, and G. Ciarimboli The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization FASEB J. 26 2011 976 986
17. J. Bray, J. Sludden, M.J. Griffin, M. Cole, M. Verrill, D. Jamieson, and A.V. Boddy Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide Br. J. Cancer 102 2010 1003 1009
18. B.C. Burckhardt, and G. Burckhardt Transport of organic anions across the basolateral membrane of proximal tubule cells Rev. Physiol. Biochem. Pharmacol. 146 2003 95 158
19. S.H. Cha, T. Sekine, H. Kusuhara, E. Yu, J.Y. Kim, D.K. Kim, Y. Sugiyama, Y. Kanai, and H. Endou Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta J. Biol. Chem. 275 2000 4507 4512
20. J. Chen, T. Terada, K. Ogasawara, T. Katsura, and K.-I. Inui Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis Am. J. Physiol. Renal Physiol. 295 2008 F247 F252
21. L. Chen, B. Pawlikowski, A. Schlessinger, S.S. More, D. Stryke, S.J. Johns, M.A. Portman, E. Chen, T.E. Ferrin, A. Sali, and K.M. Giacomini Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin Pharmacogenet. Genomics 20 2010 687 699
22. M.-K. Choi, Q.-R. Jin, Y.-L. Choi, S.-H. Ahn, M.-A. Bae, and I.-S. Song Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions Biopharm. Drug Dispos. 32 2011 175 184
23. G. Ciarimboli, D. Deuster, A. Knief, M. Sperling, M. Holtkamp, B. Edemir, H. Pavenstädt, C. Lanvers-Kaminsky, A. am Zehnhoff-Dinnesen, A.H. Schinkel, H. Koepsell, H. Jürgens, and E. Schlatter Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions Am. J. Pathol. 176 2010 1169 1180
24. G. Ciarimboli, S.K. Holle, B. Vollenbröcker, Y. Hagos, S. Reuter, G. Burckhardt, S. Bierer, E. Herrmann, H. Pavenstädt, R. Rossi, R. Kleta, and E. Schlatter New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2 Mol. Pharm. 8 2011 270 279
25. G. Ciarimboli, and E. Schlatter Regulation of organic cation transport Pflugers Arch. Eur. J. Physiol. 449 2005 423 441
26. L.M. Cotton, C.M. Rodriguez, K. Suzuki, M.-C. Orgebin-Crist, and B.T. Hinton Organic cation/carnitine transporter, OCTN2, transcriptional activity is regulated by osmotic stress in epididymal cells Mol. Reprod. Dev. 77 2010 114 125
27. C.D. Cropp, T. Komori, J.E. Shima, T.J. Urban, S.W. Yee, S.S. More, and K.M. Giacomini Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP Mol. Pharmacol. 73 2008 1151 1158
28. M. Cui, R. Aras, W.V. Christian, P.M. Rappold, M. Hatwar, J. Panza, V. Jackson-Lewis, J.A. Javitch, N. Ballatori, S. Przedborski, and K. Tieu The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway Proc. Natl. Acad. Sci. U.S.A. 106 2009 8043 8048
29. G. D'Argenio, O. Petillo, S. Margarucci, A. Torpedine, A. Calarco, A. Koverech, A. Boccia, G. Paolella, and G. Peluso Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis J. Biol. Chem. 285 2010 27078 27087
30. A. Dehghan, A. Köttgen, Q. Yang, S.-J. Hwang, W.H.L. Kao, F. Rivadeneira, E. Boerwinkle, D. Levy, A. Hofman, B.C. Astor, E.J. Benjamin, C.M. van Duijn, J.C. Witteman, J. Coresh, and C.S. Fox Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study Lancet 372 2008 1953 1961
31. M. Doblado, and K.H. Moley Facilitative glucose transporter 9, a unique hexose and urate transporter Am. J. Physiol. Endocrinol. Metab. 297 2009 E831 E835
32. K. Eder, and R. Ringseis The role of peroxisome proliferator-activated receptor a in transcriptional regulation of novel organic cation transporters Eur. J. Pharmacol. 628 2010 1 5
33. A. Enomoto, H. Kimura, A. Chairoungdua, Y. Shigeta, P. Jutabha, S.H. Cha, M. Hosoyamada, M. Takeda, T. Sekine, T. Igarashi, H. Matsuo, Y. Kikuchi, T. Oda, K. Ichida, T. Hosoya, K. Shimokata, T. Niwa, Y. Kanai, and H. Endou Molecular identification of a renal urate-anion exchanger that regulates blood urate levels Nature 417 2002 447 452
34. A. Enomoto, M.F. Wempe, H. Tsuchida, H.J. Shin, S.H. Cha, N. Anzai, A. Goto, A. Sakamoto, T. Niwa, Y. Kanai, M.W. Anders, and H. Endou Molecular identification of a novel carnitine transporter specific to human testis: Insights into the mechanism of carnitine recognition J. Biol. Chem. 277 2002 36262 36271
35. S.A. Eraly, B.A. Hamilton, and S.K. Nigam Organic anion and cation transporters occur in pairs of similar and similarly expressed genes Biochem. Biophys. Res. Commun. 300 2003 333 342
36. S.A. Eraly, and S.K. Nigam Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters Biochem. Biophys. Res. Commun. 297 2002 1159 1166
37. S.A. Eraly, V. Vallon, T. Rieg, J.A. Gangoiti, W.R. Wikoff, G. Siuzdak, B.A. Barshop, and S.K. Nigam Multiple organic anion transporters contribute to net renal excretion of uric acid Physiol. Genomics 33 2008 180 192
38. J. Fan, I. Ionita-Laza, M.B. McQueen, B. Devlin, S. Purcell, S.V. Faraone, M.H. Allen, C.L. Bowden, J.R. Calabrese, M.D. Fossey, E.S. Friedman, L. Gyulai, P. Hauser, T.B. Ketter, L.B. Marangell, D.J. Miklowitz, A.A. Nierenberg, J.K. Patel, G.S. Sachs, M.E. Thase, F.B. Molay, M.A. Escamilla, V.L. Nimgaonkar, P. Sklar, N.M. Laird, and J.W. Smoller Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus Am. J. Med. Genet. B. Neuropsychiatr. Genet. 153B 2010 29 37
39. K.K. Filipski, R.H. Mathijssen, T.S. Mikkelsen, A.H. Schinkel, and A. Sparreboom Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity Clin. Pharmacol. Ther. 86 2009 396 402
40. C. Fork, T. Bauer, S. Golz, A. Geerts, J. Weiland, D. Del Turco, E. Schömig, and D. Gründemann OAT2 catalyses efflux of glutamate and uptake of orotic acid Biochem. J. 436 2011 305 312
41. G. Fortin, K. Yurchenko, C. Collette, M. Rubio, A.-C. Villani, A. Bitton, M. Sarfati, and D. Franchimont l-Carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation Clin. Exp. Immunol. 156 2009 161 171
42. M. Fujiya, M.W. Musch, Y. Nakagawa, S. Hu, J. Alverdy, Y. Kohgo, O. Schneewind, B. Jabri, and E.B. Chang The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter Cell Host Microbe 1 2007 299 308
43. C. Funk The role of hepatic transporters in drug elimination Expert Opin. Drug Metab. Toxicol. 4 2008 363 379
44. Y. Furuichi, T. Sugiura, Y. Kato, Y. Shimada, and K. Masuda OCTN2 is associated with carnitine transport capacity of rat skeletal muscles Acta Physiol. (Oxf) 200 2010 57 64
45. Q. Garrett, S. Xu, P.A. Simmons, J. Vehige, J.L. Flanagan, and M.D. Willcox Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium Invest. Ophthalmol. Vis. Sci. 49 2008 4844 4849
46. S.E. Gilchrist, and J. Alcorn Lactation stage-dependent expression of transporters in rat whole mammary gland and primary mammary epithelial organoids Fundam. Clin. Pharmacol. 24 2010 205 214
47. S. Gong, X. Lu, Y. Xu, C.F. Swiderski, C.T. Jordan, and J.A. Moscow Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias Exp. Hematol. 30 2002 1162 1169
48. D. Gorbunov, V. Gorboulev, N. Shatskaya, T. Mueller, E. Bamberg, T. Friedrich, and H. Koepsell High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices Mol. Pharmacol. 73 2008 50 61
49. A. Grabner, S. Brast, S. Sucic, S. Bierer, B. Hirsch, H. Pavenstädt, H.H. Sitte, E. Schlatter, and G. Ciarimboli LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment Cell. Mol. Life Sci. 68 2011 4079 4090
50. S. Grigat, C. Fork, M. Bach, S. Golz, A. Geerts, E. Schömig, and D. Gründemann The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate Drug Metab. Dispos. 37 2009 330 337
51. M. Grube, H.E.U. Meyer zu Schwabedissen, D. Präger, J. Haney, K.-U. Möritz, K. Meissner, D. Rosskopf, L. Eckel, M. Böhm, G. Jedlitschky, and H.K. Kroemer Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5) Circulation 113 2006 1114 1122
52. D. Gründemann, V. Gorboulev, S. Gambaryan, M. Veyhl, and H. Koepsell Drug excretion mediated by a new prototype of polyspecific transporter Nature 372 1994 549 552
53. D. Gründemann, B. Schechinger, G.A. Rappold, and E. Schömig Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter Nat. Neurosci. 1 1998 349 351
54. S. Gupta, G. Wulf, M. Henjakovic, H. Koepsell, G. Burckhardt, and Y. Hagos Human organic cation transporter 1 is expressed in lymphoma cells and increases the susceptibility to irinotecan and paclitaxel J. Pharmacol. Exp. Ther. 341 2011 16 23
55. Y. Hagos, A. Bahn, S.V. Vormfelde, J. Brockmöller, and G. Burckhardt Torasemide transport by organic anion transporters contributes to hyperuricemia J. Am. Soc. Nephrol. 18 2007 3101 3109
56. Y. Hagos, D. Stein, B. Ugele, G. Burckhardt, and A. Bahn Human renal organic anion transporter 4 operates as an asymmetric urate transporter J. Am. Soc. Nephrol. 18 2007 430 439
57. T. Hamada, K. Ichida, M. Hosoyamada, E. Mizuta, K. Yanagihara, K. Sonoyama, S. Sugihara, O. Igawa, T. Hosoya, A. Ohtahara, C. Shigamasa, Y. Yamamoto, H. Ninomiya, and I. Hisatome Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients Am. J. Hypertens. 21 2008 1157 1162
58. C. Hilgendorf, G. Ahlin, A. Seithel, P. Artursson, A.-L. Ungell, and J. Karlsson Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines Drug Metab. Dispos. 35 2007 1333 1340
59. K. Höcherl, C. Schmidt, and M. Bucher COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex Kidney Int. 75 2009 373 380
60. G. Horvath, N. Schmid, M.A. Fragoso, A. Schmid, G.E. Conner, M. Salathe, and A. Wanner Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway Am. J. Respir. Cell Mol. Biol. 36 2007 53 60
61. K. Hosoya, A. Makihara, Y. Tsujikawa, D. Yoneyama, S. Mori, T. Terasaki, S. Akanuma, M. Tomi, and M. Tachikawa Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine J. Pharmacol. Exp. Ther. 329 2009 87 93
62. K. Hosoya, and M. Tachikawa Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins Clin. Exp. Nephrol. 15 2011 478 485
63. S. Hu, R.M. Franke, K.K. Filipski, C. Hu, S.J. Orwick, E.A. de Bruijn, H. Burger, S.D. Baker, and A. Sparreboom Interaction of imatinib with human organic ion carriers Clin. Cancer Res. 14 2008 3141 3148
64. K. Ichida, M. Hosoyamada, I. Hisatome, A. Enomoto, M. Hikita, H. Endou, and T. Hosoya Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion J. Am. Soc. Nephrol. 15 2004 164 173
65. D. Iwata, Y. Kato, T. Wakayama, Y. Sai, Y. Kubo, S. Iseki, and A. Tsuji Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart Drug Metab. Pharmacokinet. 23 2008 207 215
66. J.A. Jacobsson, T. Haitina, J. Lindblom, and R. Fredriksson Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family Genomics 90 2007 595 609
67. E. Januszewicz, M. Bekisz, J.W. Mozrzymas, and K.A. Nalecz High affinity carnitine transporters from OCTN family in neural cells Neurochem. Res. 35 2010 743 748
68. E. Januszewicz, B. Pajak, B. Gajkowska, L. Samluk, R.L. Djavadian, B.T. Hinton, and K.A. Nalecz Organic cation/carnitine transporter OCTN3 is present in astrocytes and is up-regulated by peroxisome proliferators-activator receptor agonist Int. J. Biochem. Cell Biol. 41 2009 2599 2609
69. N.N. Jong, T. Nakanishi, J.J. Liu, I. Tamai, and M.J. McKeage Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons J. Pharmacol. Exp. Ther. 338 2011 537 547
70. G. Kaler, D.M. Truong, D.E. Sweeney, D.W. Logan, M. Nagle, W. Wu, S.A. Eraly, and S.K. Nigam Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions Biochem. Biophys. Res. Commun. 351 2006 872 876
71. Y. Kato, Y. Kubo, D. Iwata, S. Kato, T. Sudo, T. Sugiura, T. Kagaya, T. Wakayama, A. Hirayama, M. Sugimoto, K. Sugihara, S. Kaneko, T. Soga, M. Asano, M. Tomita, T. Matsui, M. Wada, and A. Tsuji Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1 Pharm. Res. 27 2010 832 840
72. Y. Kato, K. Yoshida, C. Watanabe, Y. Sai, and A. Tsuji Screening of the interaction between xenobiotic transporters and PDZ proteins Pharm. Res. 21 2004 1886 1894
73. R. Kekuda, P.D. Prasad, X. Wu, H. Wang, Y.-J. Fei, F.H. Leibach, and V. Ganapathy Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta J. Biol. Chem. 273 1998 15971 15979
74. T. Keller, B. Egenberger, V. Gorboulev, F. Bernhard, Z. Uzelac, D. Gorbunov, C. Wirth, S. Koppatz, V. Dötsch, C. Hunte, H.H. Sitte, and H. Koepsell The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization J. Biol. Chem. 286 2011 37874 37886
75. Y. Kido, P. Matsson, and K.M. Giacomini Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2 J. Med. Chem. 54 2011 4548 4558
76. R. Kikuchi, H. Kusuhara, N. Hattori, I. Kim, K. Shiota, F.J. Gonzalez, and Y. Sugiyama Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 a/b and DNA methylation Mol. Pharmacol. 72 2007 1619 1625
77. K. Klein, C. Jüngst, J. Mwinyi, B. Stieger, F. Krempler, W. Patsch, J.J. Eloranta, and G.A. Kullak-Ublick The human organic anion transporter genes OAT5 and OAT7 are transactivated by hepatocyte nuclear factor-1a (HNF-1a) Mol. Pharmacol. 78 2010 1079 1087
78. D. Kobayashi, I. Tamai, Y. Sai, K. Yoshida, T. Wakayama, Y. Kido, J. Nezu, S. Iseki, and A. Tsuji Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa Reproduction 134 2007 651 658
79. Y. Kobayashi, N. Ohshiro, R. Sakai, M. Ohbayashi, N. Kohyama, and T. Yamamoto Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]) J. Pharm. Pharmacol. 57 2005 573 578
80. H. Koepsell Substrate recognition and translocation by polyspecific organic cation transporters Biol. Chem. 392 2011 95 101
81. H. Koepsell, K. Lips, and C. Volk Polyspecific organic cation iransporters: structure, function, physiological roles, and biopharmaceutical implications Pharm. Res. 24 2007 1227 1251
82. H. Koepsell, B.M. Schmitt, and V. Gorboulev Organic cation transporters Rev. Physiol. Biochem. Pharmacol. 150 2003 36 90
83. M. Kolz, T. Johnson, S. Sanna, A. Teumer, V. Vitart, M. Perola, M. Mangino, E. Albrecht, C. Wallace, M. Farrall, A. Johansson, D.R. Nyholt, Y. Aulchenko, J.S. Beckmann, S. Bergmann, M. Bochud, M. Brown, H. Campbell, J. Connell, A. Dominiczak, G. Homuth, C. Lamina, M.I. McCarthy, T. Meitinger, V. Mooser, P. Munroe, M. Nauck, J. Peden, H. Prokisch, P. Salo, V. Salomaa, N.J. Samani, D. Schlessinger, M. Uda, U. Völker, G. Waeber, D. Waterworth, R. Wang-Sattler, A.F. Wright, J. Adamski, J.B. Whitfield, U. Gyllensten, J.F. Wilson, I. Rudan, P. Pramstaller, H. Watkins, A. Doering, H.E. Wichmann, T.D. Spector, L. Peltonen, H. Völzke, R. Nagaraja, P. Vollenweider, M. Caulfield, T. Illig, and C. Gieger Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations PLoS Genet. 5 2009 e1000504
84. H. Kusuhara, T. Sekine, N. Utsunomiya-Tate, M. Tsuda, R. Kojima, S.H. Cha, Y. Sugiyama, Y. Kanai, and H. Endou Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain J. Biol. Chem. 274 1999 13675 13680
85. B. Kwok, A. Yamauchi, R. Rajesan, L. Chan, U. Dhillon, W. Gao, H. Xu, B. Wang, S. Takahashi, J. Semple, I. Tamai, J. Nezu, A. Tsuji, P. Harper, and S. Ito Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2006 R793 R802
86. Y. Lai, K.E. Sampson, L.M. Balogh, T.G. Brayman, S.R. Cox, W.J. Adams, V. Kumar, and J.C. Stevens Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1) J. Pharmacol. Exp. Ther. 334 2010 936 944
87. S. Lal, Z.W. Wong, S.R. Jada, X. Xiang, S.X. Chen, P.C. Ang, W.D. Figg, E.J. Lee, and B. Chowbay Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients Pharmacogenomics 8 2007 567 575
88. A.-M. Lamhonwah, L. Mai, C. Chung, D. Lamhonwah, C. Ackerley, and I. Tein Upregulation of mammary gland OCTNs maintains carnitine homeostasis in suckling infants Biochem. Biophys. Res. Commun. 404 2011 1010 1015
89. A. Lazar, S. Walitza, A. Jetter, M. Gerlach, A. Warnke, B. Herpertz-Dahlmann, D. Gründemann, G. Grimberg, E. Schulz, H. Remschmidt, C. Wewetzer, and E. Schömig Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder Int. J. Neuropsychopharmacol. 11 2008 35 48
90. M. Le Vee, V. Lecureur, A. Moreau, B. Stieger, and O. Fardel Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes Drug Metab. Dispos. 37 2009 2228 2235
91. J.D. Lewis, G.R. Lichtenstein, J.J. Deren, B.E. Sands, S.B. Hanauer, J.A. Katz, B. Lashner, D.H. Present, S. Chuai, J.H. Ellenberg, L. Nessel, and G.D. Wu Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial Gastroenterology 134 2008 688 695
92. F.-Y. Li, A.W. El-Hattab, E.V. Bawle, R.G. Boles, E.S. Schmitt, F. Scaglia, and L.-J. Wong Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency Hum. Mutat. 31 2010 E1632 E1651
93. C.-J. Lin, Y. Tai, M.-T. Huang, Y.-F. Tsai, H.-J. Hsu, K.-Y. Tzen, and H.-H. Liou Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents J. Neurochem. 114 2010 717 727
94. B. Ling, and J. Alcorn Acute administration of cefepime lowers l-carnitine concentrations in early lactation stage rat milk J. Nutr. 138 2008 1317 1322
95. M. Ljubojevic, D. Balen, D. Breljak, M. Kusan, N. Anzai, A. Bahn, G. Burckhardt, and I. Sabolic Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones Am. J. Physiol. Renal Physiol. 292 2007 F361 F372
96. K.S. Lovejoy, R.C. Todd, S. Zhang, M.S. McCormick, J.A. D'Aquino, J.T. Reardon, A. Sancar, K.M. Giacomini, and S.J. Lippard Cis-Diammine(pyridine) chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects Proc. Natl. Acad. Sci. U.S.A. 105 2008 8902 8907
97. T. Maeda, M. Hirayama, D. Kobayashi, K. Miyazawa, and I. Tamai Mechanism of the regulation of organic cation/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines Drug Metab. Dispos. 35 2007 394 401
98. N.G. Markova, N. Karaman-Jurukovska, K.K. Dong, N. Damaghi, K.A. Smiles, and D.B. Yarosh Skin cells and tissue are capable of using l-ergothioneine as an integral component of their antioxidant defense system Free Radical Biol. Med. 46 2009 1168 1176
99. R. Masereeuw, and F.G.M. Russel Therapeutic implications of renal anionic drug transporters Pharmacol. Ther. 126 2010 200 216
100. T. Matsuzaki, T. Morisaki, W. Sugimoto, K. Yokoo, D. Sato, H. Nonoguchi, K. Tomita, T. Terada, K.-I. Inui, A. Hamada, and H. Saito Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury Drug Metab. Dispos. 36 2008 649 654
101. Y. Meier, J.J. Eloranta, J. Darimont, M.G. Ismair, C. Hiller, M. Fried, G.A. Kullak-Ublick, and S.R. Vavricka Regional distribution of solute carrier mRNA expression along the human intestinal tract Drug Metab. Dispos. 35 2007 590 594
102. T. Minematsu, and K.M. Giacomini Interactions of tyrosine kinase inhibitors with organic cation transporters, OCTs, and multidrug and toxic compound extrusion proteins MATEs Mol. Cancer. Ther. 10 2011 531 539
103. G. Minuesa, I. Huber-Ruano, M. Pastor-Anglada, H. Koepsell, B. Clotet, and J. Martinez-Picado Drug uptake transporters in antiretroviral therapy Pharmacol. Ther. 132 2011 268 279
104. G. Minuesa, S. Purcet, I. Erkizia, M. Molina-Arcas, M. Bofill, N. Izquierdo-Useros, F.J. Casado, B. Clotet, M. Pastor-Anglada, and J. Martinez-Picado Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells J. Pharmacol. Exp. Ther. 324 2008 558 567
105. G. Minuesa, C. Volk, M. Molina-Arcas, V. Gorboulev, I. Erkizia, P. Arndt, B. Clotet, M. Pastor-Anglada, H. Koepsell, and J. Martinez-Picado Transport of lamivudine [(-)-b-l-2′,3′-dideoxy-3′-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3 J. Pharmacol. Exp. Ther. 329 2009 252 261
106. H. Miyazaki, N. Anzai, S. Ekaratanawong, T. Sakata, H.J. Shin, P. Jutabha, T. Hirata, X. He, H. Nonoguchi, K. Tomita, Y. Kanai, and H. Endou Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins J. Am. Soc. Nephrol. 16 2005 3498 3506
107. J.C. Monte, M.A. Nagle, S.A. Eraly, and S.K. Nigam Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa Biochem. Biophys. Res. Commun. 323 2004 429 436
108. S.S. More, S. Li, S.W. Yee, L. Chen, Z. Xu, D.M. Jablons, and K.M. Giacomini Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue Mol. Cancer Ther. 9 2010 1058 1069
109. J.M. Moreno-Navarrete, F.J. Ortega, J.I. Rodriguez-Hermosa, M. Sabater, G. Pardo, W. Ricart, and J.M. Fernandez-Real OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects Diabetes 60 2011 168 176
110. K. Mori, Y. Ogawa, K. Ebihara, T. Aoki, N. Tamura, A. Sugawara, T. Kuwahara, S. Ozaki, M. Mukoyama, K. Tashiro, I. Tanaka, and K. Nakao Kidney-specific expression of a novel mouse organic cation transporter-like protein FEBS Lett. 417 1997 371 374
111. H. Motohashi, Y. Sakurai, H. Saito, S. Masuda, Y. Urakami, M. Goto, A. Fukatsu, O. Ogawa, and K.I. Inui Gene expression levels and immunolocalization of organic ion transporters in the human kidney J. Am. Soc. Nephrol. 13 2002 866 874
112. H. Nakagawa, T. Hirata, T. Terada, P. Jutabha, D. Miura, K.H. Harada, K. Inoue, N. Anzai, H. Endou, K.-I. Inui, Y. Kanai, and A. Koizumi Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid Basic Clin. Pharmacol. Toxicol. 103 2008 1 8
113. M. Nakakariya, Y. Shima, Y. Shirasaka, K. Mitsuoka, T. Nakanishi, and I. Tamai Organic anion transporter OAT1 is involved in renal handling of citrulline Am. J. Physiol. Renal Physiol. 297 2009 F71 F79
114. T. Nakamura, T. Nakanishi, T. Haruta, Y. Shirasaka, J.P. Keogh, and I. Tamai Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption Mol. Pharmacol. 7 2010 187 195
115. T. Nakamura, S. Sugiura, D. Kobayashi, K. Yoshida, H. Yabuuchi, S. Aizawa, T. Maeda, and I. Tamai Decreased proliferation and erythroid differentiation of K562 cells by siRNA-induced depression of OCTN1 (SLC22A4) transporter gene Pharm. Res. 24 2007 1628 1635
116. A.T. Nies, U. Hofmann, C. Resch, E. Schaeffeler, M. Rius, and M. Schwab Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs) PLoS ONE 6 2011 e22163
117. A.T. Nies, H. Koepsell, K. Damme, and M. Schwab Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy Handb. Exp. Pharmacol. 201 2010 105 167
118. A.T. Nies, H. Koepsell, S. Winter, O. Burk, K. Klein, R. Kerb, U.M. Zanger, D. Keppler, M. Schwab, and E. Schaeffeler Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver Hepatology 50 2009 1227 1240
119. M. Nishimura, and S. Naito Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies Drug Metab. Pharmacokinet. 20 2005 452 477
120. T. Nishiwaki, Y. Daigo, M. Tamari, Y. Fujii, and Y. Nakamura Molecular cloning, mapping, and characterization of two novel human genes, ORCTL3 and ORCTL4, bearing homology to organic-cation transporters Cytogenet. Cell Genet. 83 1998 251 255
121. +/l-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment Drug Metab. Pharmacokinet. 23 2008 293 303
122. M. Okabe, G. Szakacs, M.A. Reimers, T. Suzuki, M.D. Hall, T. Abe, J.N. Weinstein, and M.M. Gottesman Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters Mol. Cancer Ther. 7 2008 3081 3091
123. M. Okuda, H. Saito, Y. Urakami, M. Takano, and K. Inui CDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2 Biochem. Biophys. Res. Commun. 224 1996 500 507
124. A. Ose, M. Ito, H. Kusuhara, K. Yamatsugu, M. Kanai, M. Shibasaki, M. Hosokawa, J.D. Schuetz, and Y. Sugiyama Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4) Drug Metab. Dispos. 37 2009 315 321
125. K. Ota, K. Ito, J. Akahira, N. Sato, T. Onogawa, T. Moriya, M. Unno, T. Abe, H. Niikura, T. Takano, and N. Yaegashi Expression of organic cation transporter SLC22A16 in human epithelial ovarian cancer: a possible role of the adriamycin importer Int. J. Gynecol. Pathol. 26 2007 334 340
126. V.D. Peltekova, R.F. Wintle, L.A. Rubin, C.I. Amos, Q. Huang, X. Gu, B. Newman, M. Van Oene, D. Cescon, G. Greenberg, A.M. Griffiths, P.H. George-Hyslop, and K.A. Siminovitch Functional variants of OCTN cation transporter genes are associated with Crohn disease Nat. Genet. 36 2004 471 475
127. L. Pochini, M. Scalise, M. Galluccio, L. Amelio, and C. Indiveri Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed in Escherichia coli Biochem. J. 439 2011 227 233
128. K. Popowski, J.J. Eloranta, M. Saborowski, M. Fried, P.J. Meier, and G.A. Kullak-Ublick The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4a and suppressed by bile acids Mol. Pharmacol. 67 2005 1629 1638
129. J.E. Race, S.M. Grassl, W.J. Williams, and E.J. Holtzman Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3) Biochem. Biophys. Res. Commun. 255 1999 508 514
130. A.N. Rizwan, and G. Burckhardt Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles Pharm. Res. 24 2007 450 470
131. A.N. Rizwan, W. Krick, and G. Burckhardt The chloride dependence of the human organic anion transporter 1 (hOAT1) is blunted by mutation of a single amino acid J. Biol. Chem. 282 2007 13402 13409
132. M. Saborowski, G.A. Kullak-Ublick, and J.J. Eloranta The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4a J. Pharmacol. Exp. Ther. 317 2006 778 785
133. H. Saito Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: Pharmacological and toxicological implications Pharmacol. Ther. 125 2009 79 91
134. J. Saito, T. Hirota, N. Kikunaga, K. Otsubo, and I. Ieiri Interindividual differences in placental expression of the SLC22A2 (OCT2) gene: Relationship to epigenetic variations in the 5′-upstream regulatory region J. Pharm. Sci. 100 2011 3875 3883
135. R. Sata, H. Ohtani, M. Tsujimoto, H. Murakami, N. Koyabu, T. Nakamura, T. Uchiumi, M. Kuwano, H. Nagata, K. Tsukimori, H. Nakano, and Y. Sawada Functional analysis of organic cation transporter 3 expressed in human placenta J. Pharmacol. Exp. Ther. 315 2005 888 895
136. M. Sato, H. Mamada, N. Anzai, Y. Shirasaka, T. Nakanishi, and I. Tamai Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human Biol. Pharm. Bull. 33 2010 498 503
137. N. Sato, K. Ito, T. Onogawa, J. Akahira, M. Unno, T. Abe, H. Niikura, and N. Yaegashi Expression of organic cation transporter SLC22A16 in human endometria Int. J. Gynecol. Pathol. 26 2007 53 60
138. E. Schaeffeler, C. Hellerbrand, A.T. Nies, S. Winter, S. Kruck, U. Hofmann, H. van der Kuip, U.M. Zanger, H. Koepsell, and M. Schwab DNA methylation is associated with downregulation of the organic cation t.ransporter OCT1 (SLC22A1) in human hepatocellular carcinoma Genome Med. 2011 10.1186/gm298
139. B.M. Schmitt, and H. Koepsell Alkali cation binding and permeation in the rat organic cation transporter rOCT2 J. Biol. Chem. 280 2005 24481 24490
140. B.M. Schmitt, D. Gorbunov, P. Schlachtbauer, B. Egenberger, V. Gorboulev, E. Wischmeyer, T. Müller, and H. Koepsell Charge-to-substrate ratio during organic cation uptake by rat OCT2 is voltage dependent and altered by exchange of glutamate 448 with glutamine Am. J. Physiol. Renal Physiol. 296 2009 F709 F722
141. G.W. Schnabolk, G.L. Youngblood, and D.H. Sweet Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20) Am. J. Physiol. Renal Physiol. 291 2006 F314 F321
142. T. Sekine, S.H. Cha, M. Tsuda, N. Apiwattanakul, N. Nakajima, Y. Kanai, and H. Endou Identification of multispecific organic anion transporter 2 expressed predominantly in the liver FEBS Lett. 429 1998 179 182
143. T. Sekine, H. Kusuhara, N. Utsunomiya-Tate, M. Tsuda, Y. Sugiyama, Y. Kanai, and H. Endou Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine Biochem. Biophys. Res. Commun. 251 1998 586 591
144. T. Sekine, N. Watanabe, M. Hosoyamada, Y. Kanai, and H. Endou Expression cloning and characterization of a novel multispecific organic anion transporter J. Biol. Chem. 272 1997 18526 18529
145. -/-) mice Mol. Genet. Metab. 92 2007 315 324
146. J.E. Shima, T. Komori, T.R. Taylor, D. Stryke, M. Kawamoto, S.J. Johns, E.J. Carlson, T.E. Ferrin, and K.M. Giacomini Genetic variants of human organic anion transporter 4 demonstrate altered transport of endogenous substrates Am. J. Physiol. Renal Physiol. 299 2010 F767 F775
147. Y. Shima, K. Teruya, and H. Ohta Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese Life Sci. 79 2006 2234 2237
148. H.J. Shin, N. Anzai, A. Enomoto, X. He, D.K. Kim, H. Endou, and Y. Kanai Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate Hepatology 45 2007 1046 1055
149. Y. Shu, S.A. Sheardown, C. Brown, R.P. Owen, S. Zhang, R.A. Castro, A.G. Ianculescu, L. Yue, J.C. Lo, E.G. Burchard, C.M. Brett, and K.M. Giacomini Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action J. Clin. Invest. 117 2007 1422 1431
150. M.S. Silverberg, R.H. Duerr, S.R. Brant, G. Bromfield, L.W. Datta, N. Jani, S.V. Kane, J.I. Rotter, S.L. Philip, S.A. Hillary, K.D. Taylor, H. Yang, J.H. Cho, J.D. Rioux, and M.J. Daly Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease Eur. J. Hum. Genet. 15 2007 328 335
151. G.D. Simonson, A.C. Vincent, K.J. Roberg, Y. Huang, and V. Iwanij Molecular cloning and characterization of a novel liver-specific transport protein J. Cell Sci. 107 1994 1065 1072
152. S. Soodvilai, J. Nantavishit, C. Muanprasat, and V. Chatsudthipong Renal organic cation transporters mediated cadmium-induced nephrotoxicity Toxicol. Lett. 204 2011 38 42
153. C. Srimaroeng, J.L. Perry, and J.B. Pritchard Physiology, structure, and regulation of the cloned organic anion transporters Xenobiotica 38 2008 889 935
154. 0,+ Am. J. Physiol. Gastrointest. Liver Physiol. 293 2007 G1046 G1053
155. W. Sun, R.R. Wu, P.D. van Poelje, and M.D. Erion Isolation of a family of organic anion transporters from human liver and kidney Biochem. Biophys. Res. Commun. 283 2001 417 422
156. D.H. Sweet, N.A. Wolff, and J.B. Pritchard Expression cloning and characterization of rOAT1, the basolateral organic anion transporter in rat kidney J. Biol. Chem. 272 1997 30088 30095
157. K. Tachampa, M. Takeda, S. Khamdang, R. Noshiro-Kofuji, M. Tsuda, S. Jariyawat, T. Fukutomi, S. Sophasan, N. Anzai, and H. Endou Interactions of organic anion transporters and organic cation transporters with mycotoxins J. Pharmacol. Sci. 106 2008 435 443
158. M. Tachikawa, Y. Takeda, M. Tomi, and K. Hosoya Involvement of OCTN2 in the transport of acetyl-l-carnitine across the inner blood-retinal barrier Invest. Ophthalmol. Vis. Sci. 51 2010 430 436
159. H. Tahara, S.W. Yee, T.J. Urban, S. Hesselson, R.A. Castro, M. Kawamoto, D. Stryke, S.J. Johns, T.E. Ferrin, P.-Y. Kwok, and K.M. Giacomini Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5) J. Pharmacol. Exp. Ther. 329 2009 262 271
160. R. Takahashi, T. Asai, H. Murakami, R. Murakami, M. Tsuzuki, Y. Numaguchi, H. Matsui, T. Murohara, and K. Okumura Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation Hypertension 50 2007 497 502
161. G. Talián, L. Lakner, J. Bene, K. Komlósi, K. Horváth, B. Gasztonyi, P. Miheller, M. Figler, G. Mózsik, Z. Tulassay, and B. Melegh Plasma carnitine ester profiles in Crohn's disease and ulcerative colitis patients with different IGR2230a-1 genotypes Int. J. Immunogenet. 36 2009 329 335
162. I. Tamai, R. Ohashi, J. Nezu, H. Yabuuchi, A. Oku, M. Shimane, Y. Sai, and A. Tsuji Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2 J. Biol. Chem. 273 1998 20378 20382
163. I. Tamai, H. Yabuuchi, J. Nezu, Y. Sai, A. Oku, M. Shimane, and A. Tsuji Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1 FEBS Lett. 419 1997 107 111
164. Y. Tanihara, S. Masuda, T. Katsura, and K.-I. Inui Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2 Biochem. Pharmacol. 78 2009 1263 1271
165. D. Taubert, N. Jung, T. Goeser, and E. Schömig Increased ergothioneine tissue concentrations in carriers of the Crohn's disease risk-associated 503F variant of the organic cation transporter OCTN1 Gut 58 2009 312 314
166. T.D. Taylor, H. Noguchi, Y. Totoki, A. Toyoda, Y. Kuroki, K. Dewar, C. Lloyd, T. Itoh, T. Takeda, D.W. Kim, X. She, K.F. Barlow, T. Bloom, E. Bruford, J.L. Chang, C.A. Cuomo, E. Eichler, M.G. FitzGerald, D.B. Jaffe, K. LaButti, R. Nicol, H.S. Park, C. Seaman, C. Sougnez, X. Yang, A.R. Zimmer, M.C. Zody, B.W. Birren, C. Nusbaum, A. Fujiyama, M. Hattori, J. Rogers, E.S. Lander, and Y. Sakaki Human chromosome 11 DNA sequence and analysis including novel gene identification Nature 440 2006 497 500
167. +/organic cation antiporters (MATE/SLC47A) Biochem. Pharmacol. 75 2008 1689 1696
168. D.S.L. Toh, S.H. Koo, L.M.G. Limenta, J.Y. Yee, M. Murray, and E.J.D. Lee Genetic variations of the SLC22A4 gene in Chinese and Indian populations of Singapore Drug Metab. Pharmacokinet. 24 2009 475 481
169. D.S.L. Toh, J.Y. Yee, S.H. Koo, M. Murray, and E.J.D. Lee Genetic variations of the SLC22A5 gene in the Chinese and Indian populations of Singapore Drug Metab. Pharmacokinet. 25 2010 112 119
170. S. Tokuhiro, R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, H. Furukawa, M. Nagashima, S. Yoshino, A. Mabuchi, A. Sekine, S. Saito, A. Takahashi, T. Tsunoda, Y. Nakamura, and K. Yamamoto An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis Nat. Genet. 35 2003 341 348
171. S.A. Tomlins, R. Mehra, D.R. Rhodes, X. Cao, L. Wang, S.M. Dhanasekaran, S. Kalyana-Sundaram, J.T. Wei, M.A. Rubin, K.J. Pienta, R.B. Shah, and A.M. Chinnaiyan Integrative molecular concept modeling of prostate cancer progression Nat. Genet. 39 2007 41 51
172. D.-A. Trégouët, I.R. König, J. Erdmann, A. Munteanu, P.S. Braund, A.S. Hall, A. Grosshennig, P. Linsel-Nitschke, C. Perret, M. DeSuremain, T. Meitinger, B.J. Wright, M. Preuss, A.J. Balmforth, S.G. Ball, C. Meisinger, C. Germain, A. Evans, D. Arveiler, G. Luc, J.-B. Ruidavets, C. Morrison, P. van der Harst, S. Schreiber, K. Neureuther, A. Schäfer, P. Bugert, N.E. El Mokhtari, J. Schrezenmeir, K. Stark, D. Rubin, H.E. Wichmann, C. Hengstenberg, W. Ouwehand, A. Ziegler, L. Tiret, J.R. Thompson, F. Cambien, H. Schunkert, and N.J. Samani Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease Nat. Genet. 41 2009 283 285
173. M.V. Tzvetkov, S.V. Vormfelde, D. Balen, I. Meineke, T. Schmidt, D. Sehrt, I. Sabolic, H. Koepsell, and J. Brockmöller The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin Clin. Pharmacol. Ther. 86 2009 299 306
174. B. Ugele, M.V. St-Pierre, M. Pihusch, A. Bahn, and P. Hantschmann Characterization and identification of steroid sulfate transporters of human placenta Am. J. Physiol. Endocrinol. Metab. 284 2003 E390 E398
175. T.J. Urban, C. Brown, R.A. Castro, N. Shah, R. Mercer, Y. Huang, C.M. Brett, E.G. Burchard, and K.M. Giacomini Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin Clin. Pharmacol. Ther. 83 2007 416 421
176. T.J. Urban, C. Yang, L.L. Lagpacan, C. Brown, R.A. Castro, T.R. Taylor, C.C. Huang, D. Stryke, S.J. Johns, M. Kawamoto, E.J. Carlson, T.E. Ferrin, E.G. Burchard, and K.M. Giacomini Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4) Pharmacogenet. Genomics 17 2007 773 782
177. Y. Uwai, H. Ida, Y. Tsuji, T. Katsura, and K.-I. Inui Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2) Pharm. Res. 24 2007 811 815
178. V. Vallon, S.A. Eraly, W.R. Wikoff, T. Rieg, G. Kaler, D.M. Truong, S.-Y. Ahn, N.R. Mahapatra, S.K. Mahata, J.A. Gangoiti, W. Wu, B.A. Barshop, G. Siuzdak, and S.K. Nigam Organic anion transporter 3 contributes to the regulation of blood pressure J. Am. Soc. Nephrol. 19 2008 1732 1740
179. P. van der Harst, S.J.L. Bakker, R.A. de Boer, B.H.R. Wolffenbuttel, T. Johnson, M.J. Caulfield, and G. Navis Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms Hum. Mol. Genet. 19 2010 387 395
180. N. van Vlies, S. Ferdinandusse, M. Turkenburg, R.J.A. Wanders, and F.M. Vaz PPAR a-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation Biochim. Biophys. Acta 1767 2007 1134 1142
181. A.L. Vanwert, M.R. Gionfriddo, and D.H. Sweet Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology Biopharm. Drug Dispos. 31 2010 1 71
182. J. Vazquez-Mellado, A.L. Jimenez-Vaca, S. Cuevas-Covarrubias, V. varado-Romano, G. Pozo-Molina, and R. Burgos-Vargas Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout Rheumatology (Oxford) 46 2007 215 219
183. +-D-glucose cotransporter SGLT1 Am. J. Physiol. Renal Physiol. 291 2006 F1213 F1223
184. V. Vialou, A. Amphoux, R. Zwart, B. Giros, and S. Gautron Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation J. Neurosci. 24 2004 2846 2851
185. S.V. Vormfelde, M. Schirmer, Y. Hagos, M.R. Toliat, S. Engelhardt, I. Meineke, G. Burckhardt, P. Nürnberg, and J. Brockmöller Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters Br. J. Clin. Pharmacol. 62 2006 323 335
186. C. Wang, I.P. Uray, A. Mazumdar, J.A. Mayer, and P.H. Brown SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE) Breast Cancer Res. Treat. 134 2012 101 115
187. L. Wang, A. Giannoudis, S. Lane, P. Williamson, M. Pirmohamed, and R.E. Clark Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia Clin. Pharmacol. Ther. 83 2007 258 264
188. T. Wang, J. Li, F. Chen, Y. Zhao, X. He, D. Wan, and J. Gu Choline transporters in human lung adenocarcinoma: expression and functional implications Acta Biochim. Biophys. Sin. (Shanghai) 39 2007 668 674
189. T.N. Winter, W.F. Elmquist, and C.A. Fairbanks OCT2 and MATE1 provide bidirectional agmatine transport Mol. Pharm. 8 2011 133 142
190. K.A. Wojtal, J.J. Eloranta, P. Hruz, H. Gutmann, J. Drewe, A. Staumann, C. Beglinger, M. Fried, G.A. Kullak-Ublick, and S.R. Vavricka Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients Drug Metab. Dispos. 37 2009 1871 1877
191. C.C. Wong, D. Barron, C. Orfila, F. Dionisi, P. Krajcsi, and G. Williamson Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters Mol. Nutr. Food Res. 55 2011 979 988
192. C.C. Wong, N.P. Botting, C. Orfila, N. Al-Maharik, and G. Williamson Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6) Biochem. Pharmacol. 81 2011 942 949
193. X. Wu, P.D. Prasad, F.H. Leibach, and V. Ganapathy CDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family Biochem. Biophys. Res. Commun. 246 1998 589 595
194. G. Xu, V. Bhatnagar, G. Wen, B.A. Hamilton, S.A. Eraly, and S.K. Nigam Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)] Kidney Int. 68 2005 1491 1499
195. X. Xue, L.-K. Gong, K. Maeda, Y. Luan, X.-M. Qi, Y. Sugiyama, and J. Ren Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I Mol. Pharm. 8 2011 2183 2192
196. K. Yakushiji, S. Kai, M. Yamauchi, M. Kuwajima, Y. Osada, and K. Toshimori Expression and distribution of OCTN2 in mouse epididymis and its association with obstructive azoospermia in juvenile visceral steatosis mice Int. J. Urol. 13 2006 420 426
197. D. Yao, M. Kuwajima, Y. Chen, M. Shiota, Y. Okumura, H. Yamada, and H. Kido Impaired long-chain fatty acid metabolism in mitochondria causes brain vascular invasion by a non-neurotropic epidemic influenza A virus in the newborn/suckling period: implications for influenza-associated encephalopathy Mol. Cell. Biochem. 299 2007 85 92
198. M. Yeager, N. Orr, R.B. Hayes, K.B. Jacobs, P. Kraft, S. Wacholder, M.J. Minichiello, P. Fearnhead, K. Yu, N. Chatterjee, Z. Wang, R. Welch, B.J. Staats, E.E. Calle, H.S. Feigelson, M.J. Thun, C. Rodriguez, D. Albanes, J. Virtamo, S. Weinstein, F.R. Schumacher, E. Giovannucci, W.C. Willett, G. Cancel-Tassin, O. Cussenot, A. Valeri, G.L. Andriole, E.P. Gelmann, M. Tucker, D.S. Gerhard, J.F. Fraumeni Jr.; R. Hoover, D.J. Hunter, S.J. Chanock, and G. Thomas Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 Nat. Genet. 39 2007 645 649
199. Q. Zhang, M. Hong, P. Duan, Z. Pan, J. Ma, and G. You Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway J. Biol. Chem. 283 2008 32570 32579
200. T. Zhang, C.D. Xiang, D. Gale, S. Carreiro, E.Y. Wu, and E.Y. Zhang Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition Drug Metab. Dispos. 36 2008 1300 1307
201. F. Zhou, N.P. Illsley, and G. You Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells Eur. J. Pharm. Sci. 27 2006 518 523
202. R.M. Zürcher, H.A. Bock, and G. Thiel Hyperuricaemia in cyclosporin-treated patients: a GFR-related effect Nephrol. Dial. Transplant. 11 1996 153 158